JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB108905

Tissue type Plasminogen Activator Activity Assay Kit (Colorimetric, Human)

5

(1 Review)

|

(13 Publications)

Tissue type Plasminogen Activator Activity Assay Kit (Colorimetric, Human) ab108905 is used to measure Human Tissue type Plasminogen Activator activity in serum and plasma.

View Alternative Names

Tissue-type plasminogen activator, t-PA, t-plasminogen activator, tPA, PLAT

6 Images
Functional Studies - Tissue type Plasminogen Activator Activity Assay Kit (Colorimetric, Human) (AB108905)
  • FuncS

Supplier Data

Functional Studies - Tissue type Plasminogen Activator Activity Assay Kit (Colorimetric, Human) (AB108905)

Tissue type Plasminogen Activator Chromogenic Activity Standard curve

Functional Studies - Tissue type Plasminogen Activator Activity Assay Kit (Colorimetric, Human) (AB108905)
  • FuncS

Lab

Functional Studies - Tissue type Plasminogen Activator Activity Assay Kit (Colorimetric, Human) (AB108905)

O.D's of various dilutions of human plasma after 20hrs using ab108905

Functional Studies - Tissue type Plasminogen Activator Activity Assay Kit (Colorimetric, Human) (AB108905)
  • FuncS

Lab

Functional Studies - Tissue type Plasminogen Activator Activity Assay Kit (Colorimetric, Human) (AB108905)

tPA measured in biological fluids showing activity (IU) per mL of tested sample

Functional Studies - Tissue type Plasminogen Activator Activity Assay Kit (Colorimetric, Human) (AB108905)
  • FuncS

Lab

Functional Studies - Tissue type Plasminogen Activator Activity Assay Kit (Colorimetric, Human) (AB108905)

Alkaline phosphatase Conjugation Kit - Lightning-Link® labeling MPC and MYSV6 polyclonal antibodies for microfluidic sandwich ELISA. Time course of tPA measured in biological fluids showing optical densities.

Functional Studies - Tissue type Plasminogen Activator Activity Assay Kit (Colorimetric, Human) (AB108905)
  • FuncS

Lab

Functional Studies - Tissue type Plasminogen Activator Activity Assay Kit (Colorimetric, Human) (AB108905)

Change of absorbance per min. of various concentrations of tPA standard

Functional Studies - Tissue type Plasminogen Activator Activity Assay Kit (Colorimetric, Human) (AB108905)
  • FuncS

Lab

Functional Studies - Tissue type Plasminogen Activator Activity Assay Kit (Colorimetric, Human) (AB108905)

Standard curve (colorimetric) : mean of duplicates (+/-SD) with background readings subtracted

Key facts

Detection method

Colorimetric

Sample types

Plasma, Serum

Reacts with

Human

Assay type

Enzyme activity (quantitative)

Sensitivity

= 0.12 IU/mL

Range

0.156 - 40 IU/mL

Assay time

1h

Assay Platform

Microplate reader

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Enzyme activity assay": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Tissue type Plasminogen Activator Activity Assay Kit (Colorimetric, Human) ab108905 is used to measure Human Tissue type Plasminogen Activator activity in serum and plasma samples.

The tPA assay protocol measures the ability of Tissue type Plasminogen Activator to activate the plasminogen to plasmin in coupled or indirect assays that contain Tissue type Plasminogen Activator, plasminogen, and a plasmin-specific synthetic substrate. The amount of plasmin produced is quantitated using a highly specific plasmin substrate releasing a yellow para-nitroaniline (pNA) chromophore. The change in absorbance of the pNA in the reaction solution at 405 nm is directly proportional to the Tissue type Plasminogen Activator enzymatic activity.

The entire kit may be stored at -20°C for long term storage before reconstitution - Avoid repeated freeze-thaw cycles.

Previously called Tissue type Plasminogen Activator Human Chromogenic Activity Assay Kit.

Tissue type Plasminogen Activator (tPA) is a 68 kDa serine protease that converts the zymogen plasminogen into the active serine protease plasmin which digests fibrin and induces the dissolution of fibrin clots. Tissue type Plasminogen Activator is synthesized by endothelial cells in normal blood vessels and displays relatively high affinity for fibrin, suggesting that it functions predominately in physiological thrombolysis in vivo.

What's included?

{ "values": { "100Test": { "sellingSize": "100 Test", "publicAssetCode":"ab108905-100Test", "assetComponentDetails": [ { "size":"1 x 1 Unit", "name":"Tissue type Plasminogen Activator Standard", "number":"AB108905-CMP06", "productcode":"" }, { "size":"1 x 1 Unit", "name":"Microplate 1 96 well polystyrene microplate (12 strips of 8 wells)", "number":"AB108905-CMP04", "productcode":"" }, { "size":"1 x 30 mL", "name":"1X Diluent", "number":"AB108905-CMP02", "productcode":"" }, { "size":"3 x 1 Vial", "name":"Human Plasminogen", "number":"AB108905-CMP01", "productcode":"" }, { "size":"2 x 1 Unit", "name":"Plasmin Substrate", "number":"AB108905-CMP03", "productcode":"" }, { "size":"3 x 1 Unit", "name":"Sealing Tapes", "number":"AB108905-CMP05", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
Multi
Storage information
Please refer to protocols

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Tissue Plasminogen Activator (tPA) also known as a plasminogen activator acts mechanically to convert plasminogen to plasmin a serine protease. This reaction occurs at the surface of a fibrin clot leading to clot degradation a process known as fibrinolysis. tPA has a molecular mass of approximately 70 kDa. It is mainly expressed in vascular endothelial cells and is released into the bloodstream in response to stimuli such as circulatory stasis or endothelial damage.
Biological function summary

TPA plays a critical role in thrombolysis by breaking down blood clots into their soluble components. It regulates plasminogen function by cleaving this zymogen to yield the active protease plasmin. This function makes tPA integral in maintaining hemostasis and it does not form a part of a larger protein complex. The activity and the regulation of tPA are important for preventing pathologic clotting which can lead to cardiovascular complications.

Pathways

TPA is central to the fibrinolytic pathway. This pathway facilitates the conversion of plasminogen to plasmin enabling clot resolution. In addition tPA interacts with other proteins such as urokinase plasminogen activator (uPA) and inhibitors like plasminogen activator inhibitor-1 (PAI-1). The balance between tPA and its inhibitors is important for the regulation of fibrinolytic activity impacting hemostatic and thrombotic events.

TPA connects closely with conditions like stroke and myocardial infarction due to its thrombolytic properties. In ischemic stroke excessive or insufficient tPA activity can disrupt normal blood flow leading to tissue damage. Additionally in myocardial infarction tPA's role in breaking down clots proves important for restoring coronary blood flow. It is also linked with proteins like fibrinogen as they serve as substrates in the clot degradation process and with PAI-1 which modulates its activity and influences disease progression.

Product protocols

Target data

Converts the abundant, but inactive, zymogen plasminogen to plasmin by hydrolyzing a single Arg-Val bond in plasminogen. By controlling plasmin-mediated proteolysis, it plays an important role in tissue remodeling and degradation, in cell migration and many other physiopathological events. During oocyte activation, plays a role in cortical granule reaction in the zona reaction, which contributes to the block to polyspermy (By similarity).
See full target information PLAT

Publications (13)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:3852 PubMed40274794

2025

A facultative plasminogen-independent thrombolytic enzyme from Sipunculus nudus.

Applications

Unspecified application

Species

Unspecified reactive species

Mingqing Tang,Guoxing Ma,Chunyan Xu,Hui Yang,Hongjun Lin,Chao Bian,Chengjia Hu,Meiling Lu,Lei Chen,Wencai Jie,Zhen Yue,Jianbo Jian,Yuqing Sun,Hui Yan,Jingjing Zhou,Xianying Zhang,Shengye Liao,Zhaofa Li,Shuangfeng Cai,Yaqing Wu,Kexin Yang,Yanan Xiong,Yonggang Zhao,Zhimin Lv,Xiaoming Xu,Chuang Liu,Pengliang Xin,Lichao Ye,Xiuling Cui,Qiong Shi,Xi Chen,Ruian Xu

Research and practice in thrombosis and haemostasis 7:102164 PubMed37680312

2023

Plasma tissue-type plasminogen activator is associated with lipoprotein(a) and clinical outcomes in hospitalized patients with COVID-19.

Applications

Unspecified application

Species

Unspecified reactive species

Ziyu Zhang,Wen Dai,Wen Zhu,Maya Rodriguez,Hayley Lund,Yuhe Xia,Yiliang Chen,Mary Rau,Ellen Anje Schneider,Mary Beth Graham,Shawn Jobe,Demin Wang,Weiguo Cui,Renren Wen,Sidney W Whiteheart,Jeremy P Wood,Roy Silverstein,Jeffery S Berger,Lisa Baumann Kreuziger,Tessa J Barrett,Ze Zheng

Molecular neurobiology 60:6441-6465 PubMed37458985

2023

Extracellular Vesicle-Serpine-1 Affects Neural Progenitor Cell Mitochondrial Networks and Synaptic Density: Modulation by Amyloid Beta and HIV-1.

Applications

Unspecified application

Species

Unspecified reactive species

Ibolya E András,Nelson Serrano,Irina Djuraskovic,Nikolai Fattakhov,Enze Sun,Michal Toborek

Frontiers in pharmacology 14:1190476 PubMed37180699

2023

Immunocytoprotection after reperfusion with Kv1.3 inhibitors has an extended treatment window for ischemic stroke.

Applications

Unspecified application

Species

Unspecified reactive species

Ruth D Lee,Yi-Je Chen,Latika Singh,Hai M Nguyen,Heike Wulff

Translational stroke research 15:518-532 PubMed37088858

2023

Repurposing the K3.1 Blocker Senicapoc for Ischemic Stroke.

Applications

Unspecified application

Species

Unspecified reactive species

Ruth D Lee,Yi-Je Chen,Hai M Nguyen,Latika Singh,Connor J Dietrich,Benjamin R Pyles,Yanjun Cui,Jonathan R Weinstein,Heike Wulff

Molecular vision 27:691-705 PubMed35002214

2021

Tissue plasminogen activator rescues steroid-induced outflow facility reduction via non-enzymatic action.

Applications

Unspecified application

Species

Unspecified reactive species

Sofya Gindina,Arturo O Barron,Yan Hu,Antonios Dimopoulos,John Danias

Cancer reports (Hoboken, N.J.) 5:e1498 PubMed34240826

2021

The association between Annexin A2 and epithelial cell adhesion molecule in breast cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Saad Misfer Al-Qahtani,Salah Eldin Gadalla,Min Guo,Christer Ericsson,Daniel Hägerstrand,Monica Nistér

The Journal of clinical investigation 130:4348-4359 PubMed32657780

2020

Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity.

Applications

Unspecified application

Species

Unspecified reactive species

Ze Zheng,Keiko Nakamura,Shana Gershbaum,Xiaobo Wang,Sherry Thomas,Marc Bessler,Beth Schrope,Abraham Krikhely,Rui-Ming Liu,Lale Ozcan,José A López,Ira Tabas

Journal of neurochemistry 152:468-481 PubMed31602645

2019

A multimolecular signaling complex including PrP and LRP1 is strictly dependent on lipid rafts and is essential for the function of tissue plasminogen activator.

Applications

Unspecified application

Species

Unspecified reactive species

Vincenzo Mattei,Valeria Manganelli,Stefano Martellucci,Antonella Capozzi,Elisabetta Mantuano,Agostina Longo,Alberto Ferri,Tina Garofalo,Maurizio Sorice,Roberta Misasi

Journal of stroke and cerebrovascular diseases : t 27:2720-2724 PubMed30037651

2018

Helicopter "Drip and Ship" Flights Do Not Alter the Pharmacological Integrity of rtPA.

Applications

Unspecified application

Species

Unspecified reactive species

Brett A Faine,Sanjana Dayal,Rahul Kumar,Steven R Lentz,Enrique C Leira
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com